John Woolcott

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis

Carlo A. Marra, John Woolcott, Jacek A. Kopec et al. · Social Science & Medicine · 2004 · 396 citations

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen et al. · Annals of the Rheumatic Diseases · 2020 · 214 citations · Full text

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry

Manasi Agrawal, Erica J. Brenner, Xian Zhang et al. · Inflammatory Bowel Diseases · 2020 · 57 citations · Full text

Long Covid, Tofacitinib Therapy, Covid-19 Pandemic +8

FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS

Maxime Dougados, Désirée van der Heijde, Clifton O. Bingham et al. · Annals of the Rheumatic Diseases · 2020 · 52 citations · Full text

Does physical activity reduce seniors' need for healthcare?: a study of 24 281 Canadians

John Woolcott, Maureen C. Ashe, William C. Miller et al. · British Journal of Sports Medicine · 2009 · 51 citations